Market Research Logo

Avanir Pharmaceuticals Inc - Strategic SWOT Analysis Review

Avanir Pharmaceuticals Inc - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Avanir Pharmaceuticals Inc (Avanir) a subsidiary of Otsuka America, Inc. is a biopharmaceutical company which focuses on developing medicines for patients suffering from central nervous system disorders. The company’s lead products include NUEDEXTA (AVP-923), a first-in-class dual N-methyl-D-aspartate (NMDA) rector antagonist and sigma-1 agonist is approved in the US and Europe for the treatment of pseudobulbar affect (PBA); and ONZETRA Xsail is for the treatment of migraine with or without aura in adult is approved in the US. Its AVP-786 has been developed for the treatment of depression and schizophrenia. The company is also developing various products under pipeline for the treatment of CNS disorders. Avanir is headquartered in Aliso Viejo, California, the US.

Avanir Pharmaceuticals Inc Key Recent Developments

Nov 29,2017: Avanir restructures, will cut 11% of US workforce

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
Avanir Pharmaceuticals Inc - Key Facts
Avanir Pharmaceuticals Inc - Key Employees
Avanir Pharmaceuticals Inc - Key Employee Biographies
Avanir Pharmaceuticals Inc - Major Products and Services
Avanir Pharmaceuticals Inc - History
Avanir Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Avanir Pharmaceuticals Inc - Business Description
Avanir Pharmaceuticals Inc - Corporate Strategy
Avanir Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Avanir Pharmaceuticals Inc - Strengths
Avanir Pharmaceuticals Inc - Weaknesses
Avanir Pharmaceuticals Inc - Opportunities
Avanir Pharmaceuticals Inc - Threats
Avanir Pharmaceuticals Inc - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Avanir Pharmaceuticals Inc, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Avanir Pharmaceuticals Inc, Key Facts
Avanir Pharmaceuticals Inc, Key Employees
Avanir Pharmaceuticals Inc, Key Employee Biographies
Avanir Pharmaceuticals Inc, Major Products and Services
Avanir Pharmaceuticals Inc, History
Avanir Pharmaceuticals Inc, Subsidiaries
Avanir Pharmaceuticals Inc, Key Competitors
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Avanir Pharmaceuticals Inc, Recent Deals Summary
List of Figures
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report